Martina Flöel

OXEA is the second largest manufacturer of Oxo chemicals and 1 in the merchant market. The company has more than 75 years of experience in the production of Oxo chemicals, built upon processes originally invented by its predecessor companies Celanese/Hoechst and Degussa. This experience has enabled the company to develop its core competencies and proprietary technologies across the entire Oxo intermediates and Oxo Derivatives value chain. It has production facilities in Germany (Oberhausen and Marl), in the United States (Bay City and Bishop) and in the Netherlands (Amsterdam). OXEA is managed by a highly experienced, international Management Team. Active quality and environmental management as well as occupational safety and healthy are key elements of OXEA's policy. A clearly defined strategy resulted in implementation records for the past three years and determines OXEA's future.

OQ Chemicals GmbH manufactures Oxo intermediates and Oxo derivatives. It offers n-butyl acetate, i-butyl acetate, and n-propyl acetate ester products, aldehydes, and alcohols for use in downstream production processes such as surface coatings in building materials or automotive sectors, as well as for the production of paints, lubricants, ink products, fuel additives, and detergent products. The firm also provides carboxylic acids, polyols, higher aldehydes and specialty derivatives, amines, and specialty esters for synthetic lubricants, coatings, agrochemicals, and phthalate free plasticizers. The company was founded on March 1, 2007 and is headquartered in Marl, Germany.

OQ Chemicals Corp. wholesales and supplies drugs and other chemical products. The company is headquartered in Dallas, TX.

Celanese AG is a producer of acetyl products, including acetic acid, vinyl acetate monomer (VAM), polyacetal products (POM), as well as engineered polymers used in consumer and industrial products designed to meet technical customer requirements. It is a subsidiary of Celanese Corp. and headquartered in Kronberg, Germany.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Oxea Holding GmbH acquires, holds, manages, and sells participations in companies that are engaged in research, development, manufacture, processing, marketing, and distribution of organic chemicals. The company was founded on November 30, 2006 and is headquartered in Monheim, Germany.